Nasdaq

QIAGEN Receives FDA Emergency Use Authorization for NeuMoDx Multiplex Test Expanding COVID-19 Portfolio

NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test receives Emergency Use Authorization by FDA The 4-plex test utilizes the high-throughput, automated testing capabilities of the NeuMoDx systems, which has ...
Nasdaq

QIAGEN's (QGEN) NeuMoDx Multiplex Test Receives FDA EUA

QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...
WLWT

Customers can get tested for flu, RSV, COVID-19 all at once at Kroger's Little Clinics

Customers can make sure they are getting the right treatment for their illnesses by taking a three-in-one multiplex test at Kroger's Little Clinics that test for the flu, RSV and COVID-19 all at ...
Business Wire

Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use

SAN DIEGO--(BUSINESS WIRE)--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that it has been awarded a new approximately $28 million contract by the Biomedical Advanced ...
Business Wire

Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis

VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), ...
Technology Networks

From Discovery to Clinical Studies, Biomarkers Require Multiplex Assays

This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.